What LSF Medical Solutions does

LSF Medical Solutions is a private, founder-led medical device company founded in 2022 and based in Iowa City, Iowa. The company is developing Pneumero™, a home-based respiratory monitoring system that adapts clinical-grade gas washout technology — previously available only at select hospitals — for use in patients' homes. Its primary mission is to reduce reliance on urgent care, emergency room, and intensive care interventions among patients with chronic lung diseases by enabling continuous, clinical-grade respiratory monitoring, early crisis detection, and direct communication with healthcare providers. The company is led by Founder/CEO Melissa L. Bates, PhD, MBA, FAPS, who brings nearly 25 years of experience in novel cardiorespiratory analytics, supported by a CMO, CTO, and Chief Patient Experience Officer.

The underlying technology centers on a proprietary gas washout measurement architecture, trademarked as Pneumero™, which is being adapted from the clinical setting to a home form factor. Functional features described include real-time monitoring and alerts, seamless healthcare provider integration, a user-friendly patient interface, and early detection capabilities intended to prevent respiratory crises. The company has not disclosed hardware specifications, regulatory pathway status (FDA clearance is not mentioned), proprietary AI/ML components, or pricing details in the available source material.

LSF Medical Solutions operates an enterprise field sales go-to-market motion, recruiting established respiratory care programs at healthcare institutions as beta sites. Beta site requirements include clinical trial experience, dedicated program staff, patient populations with chronic lung disease, and commitment to structured feedback and evaluation cycles. To date, the company has secured approximately $100,000 in non-dilutive support: a $50,000 award from the Iowa Economic Development Authority (May 2025) and $50,000 in AWS cloud credits via the inaugural Iowa JPEC AI Pitch Competition (November 2025). The company is pre-revenue, with no disclosed paying customers, contract values, or commercial launch timeline.

Name

LSF Medical Solutions

Legal name

LSF Medical Solutions

Website

https://lsfmedicalsolutions.wordpress.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

LSF Medical Solutions is a pre-revenue Iowa City-based medical device startup developing Pneumero™, a home-adapted gas washout respiratory monitor for patients with chronic lung diseases. The company sells to healthcare institutions via an enterprise beta-site recruitment model.

Ownership category

akta.pro rank

Product category

Respiratory Care Medical Devices

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD)

akta.pro secondary industries

Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH), Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI)

Keywords

• Respiratory monitoring devices
• Home medical devices
• Gas washout technology
• Chronic lung disease care
• Clinical-grade monitoring

Headquarters

HQ city

Iowa City

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Pneumero Device and Monitoring Services: Medical device sales with associated monitoring services for home-based respiratory care. The company is in beta testing phase with healthcare institutions, suggesting an enterprise/hardware sales model with potential ongoing monitoring service components.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

LSF Medical Solutions develops and sells Pneumero™, a home-based respiratory monitoring system that uses highly sensitive gas washout technology to provide clinical-grade accuracy for patients with chronic lung diseases. The device enables real-time monitoring, early detection of respiratory crises, and direct communication with healthcare providers, with the company currently recruiting healthcare institutions as beta testing partners.

Product overview

LSF Medical Solutions offers a single unified product, Pneumero™, a revolutionary home-based respiratory monitoring system. Pneumero™ brings highly sensitive gas washout technology from the clinic to the living room, providing clinical-grade accuracy for patients with chronic lung lung diseases. The product features real-time monitoring and alerts, seamless healthcare provider integration, and a user-friendly interface for patients and families.

Differentiator

Problem solved

Functional benefit

Brands

• Pneumero™: Revolutionary home-based respiratory monitoring technology that brings clinical-grade gas washout technology from the clinic to the living room for patients with chronic lung diseases.

Products and services

• Pneumero™

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Propeller Health: Propeller Health pioneered sensor-based home respiratory monitoring for asthma and COPD patients, providing real-time inhaler use and lung function insights. Now part of ResMed, it competes directly with LSF in connected home respiratory care.
• NuvoAir: NuvoAir delivers connected home spirometry and respiratory care management for chronic lung disease patients, offering clinician dashboards similar to those implied by Pneumero's value proposition.
• Adherium: Adherium develops connected inhaler sensors and remote respiratory monitoring solutions for asthma and COPD, overlapping directly with LSF's chronic lung disease home monitoring focus.
• Spire Health: Spire Health produces wearable-based remote respiratory monitoring products that capture continuous breathing patterns at home, positioning it as a comparable consumer-grade respiratory data platform.

Emerging players

• Wellinks: Wellinks provides a connected respiratory care management platform combining virtual pulmonary rehab, COACH data, and provider dashboards—adjacent to LSF's home monitoring thesis for chronic lung disease.
• Vyaire Medical: Vyaire Medical specializes in respiratory diagnostics and ventilation products, with overlapping pulmonary function testing expertise and channels into respiratory care programs similar to LSF's beta-site targets.
• Aptar Digital Health: Aptar's digital health division develops connected drug delivery and respiratory adherence platforms, providing an adjacent, technology-enabled view into the chronic lung disease home monitoring landscape where LSF operates.

Broad incumbents

• ResMed: ResMed is a global leader in sleep and respiratory care devices and acquired Propeller Health. It operates a broad connected-health portfolio that competes with and dwarfs LSF's narrower home respiratory offering.
• Philips Respironics: Philips Respironics is a major manufacturer of sleep and respiratory care devices, including home ventilation and connected therapy solutions that overlap with LSF's clinical-grade home respiratory monitoring focus.
• Fisher & Paykel Healthcare: Fisher & Paykel Healthcare is an established respiratory care device maker with home humidification, CPAP, and connected respiratory products, providing a comparable clinical-grade home respiratory category context.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LSF Medical Solutions